Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

CAR T-cell therapy modifies a patient's immune cells to target cancer, offering potential cures for blood cancers like lymphoma and myeloma. Up to 40% of lymphoma patients may achieve remission after ...

Researchers classify the subtypes and activity of immune cells in tongue squamous cell carcinoma microenvironment, with potential applications in providing personalized treatment. Immunotherapies are ...

For all indications with continuous therapies, the median cost rose from $10,784 per month in 2017 to $17,936 per month in 2021. Researchers observed an overall increase in the absolute median cost of ...

Late-breaking data from DESTINY-Breast09 and DESTINY-Gastric04 phase 3 trials showcase how ENHERTU will potentially redefine standard of care for first-line HER2 positive metastatic breast cancer and ...

Minimally invasive techniques enable partial nephrectomies, preserving kidney function in most kidney cancer cases. Multidisciplinary care integrates surgery with targeted therapies and ...

Cancer treatment has evolved tremendously over the past decades with new treatments like immune checkpoint inhibitors, which can activate the immune system to kill tumor cells, providing some of the ...

Immunotherapy with and without radiotherapy following the diagnosis of bone metastasis for stage 4 non-small cell carcinoma. Efficacy and safety of nivolumab plus chemotherapy versus chemotherapy ...